1Sugiyama T,Ishii S,Yamamoto Ji,et al.cDNA macroarray ana-lysis of gene expression in synoviocytes stimulated with TNFalpha[J].FEBS Lett,2002,517(1/2/3):121-128.
2Hadler-Olsen E,Winberg JO,Uhlin-Hansen L.Matrix metallo-proteinases in cancer:their value as diagnostic and prognosticmarkers and therapeutic targets[J].Tumour Biol,2013,34(4):2041-2051.
3Wong CM,Ng YL,Lee JM,et al.Tissue factor pathway inhibitor-2as a frequently silenced tumor suppressor gene in hepatocellularcarcinoma[J].Hepatology,2007,45(5):1129-1167.
4Wojtukiewicz MZ,Sierko E,Zimnoch L,et al.Immunohistoche-mical localization of tissue factor pathway inhibitor-2 in humantumor tissue[J].Thromb Haemost,2003,90(1):140-146.
5Stamenkovic I.Extracellular matrix remodelling:the role of matrixmetalloproteinase[J].J Pathol,2003,200(4):448-464.
6Noel A,Jost M,Maquoi E.Matrix metalloproteinases at cancertumor-host interface[J].Semin Cell Dev Biol,2008,19(1):52-60.
7Chand HS,Du X,Ma D,et al.The effect of human tissue factorpathway inhibitor-2 on the growth and metastasis of fibrosarcomatumors in athymic mice[J].Blood,2004,103(3):1069-1077.
8Ribarska T,Ingenwerth M,Goering W,et al.Epigenetic inacti-vation of the placentally imprinted tumor suppressor gene TFPI2in prostate carcinoma[J].Cancer Genomics Proteomics,2010,7(2):51-60.
9Hibi K,Goto T,Kitamura YH,Yokomizo K,et al.Methylation ofTFPI2 gene is frequently detected in advanced well-differentiatedcolorectal cancer[J].Anticancer Res,2010,30(4):1205-1207.
10Hube F,Reverdiau P,Iochmann S,et al.Characterization andfunctional analysis of TFPI-2 gene promoter in a human chorio-carcinoma cell line[J].Thromb Res,2003,109(4);207-215.
